D.E. KUTEPOV

Federal State Institution «Clinical hospital №1» at Administration of the President of the Russian Federation, 10 Starovolynskaya St., Moscow, Russian Federation, 121352

Kutepov D.E. — PhD (Medicine), Head of the Department of Extracorporal Techniques, tel. (495) 441-30-74, е-mail: eml@volynka.ru

The study included 132 patients with cirrhosis. Comparative characteristics of hemodynamic is carried out during medication therapy and treatment augmented with MARS sessions (molecular adsorbing recirculating system). Analysis of the obtained results demonstrated the positive impact of MARS on hemodynamic parameters in patients with cirrhosis compared with patients who were only exposed to drug therapy. Therefore, MARS could serve as an optional method for patients with cirrhosis complicated by hyperdinamic circulation.

Key words: cirrhosis, hyperdinamic circulation, MARS.

REFERENCES

1. Sherlock S., Dooley J. Zabolevaniya pecheni i zhelchnykh putey [Diseases of the liver and biliary tract]. Moscow: GEOTAR-MED, 2002. 864 p.

2. Catalina M-V., Barriro J., Anaya F. et al. Hepatic and systemic haemodinamic chandes after MARS in patients with acute on chronic liver failure. Liver International, 2003, vol. 23 (Suppl. 3), pp. 39-43.

3. Schmidt L.E., Wang L.P., Hansen B.A. et al. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl, 2003, vol. 9, pp. 290-297.

4. Laleman W., Van Landeghem L., Wilmer A. et al. Portal hypertension: from pathophysiology to clinical practice. Liver Int, 2005, vol. 25, pp. 1079-1090.

5. Mшller S., Henriksen J.H. Cardiovascular complications of cirrhosis. Gut, 2008, vol. 57, pp. 268-278.

6. Wiest R., Groszmann R.J. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatol, 2002, vol. 35, pp. 478-491.

7. Wauters J., Wilmer A. Albumin dialysis: current practice and future options. Liver International, 2011, vol. 31, pp. 9-12.

8. Kutepov DE, Beekeeper IN, AV Popov etc. Rol’ i mesto al’buminovogo dializa v lechenii bol’nykh s pechenochnoy nedostatochnost’yu [The role and place of albumin dialysis in patients with liver failure]. Anesthesiology and resuscitation, 2010, no. 2, pp. 52-57.

9. Tran-Zweifel D., Goubaux B., Bornard L. et al. Molecular adsorbent recirculating systemm in patients with acute liver failure: prospective follow-up. Crit. Care, 2010, vol. 14, no. 1, p. 539.

10. Nevens F., Laleman W. Artificial liver support devices as treatment option for liver failure. Clin. Gastroenterol, 2012, vol. 26, pp. 17-26.